Showing results (111-120 of 404) with videos related to

Sort By:
Pageof 41
In Vivo (Athens, Greece)|August 26, 2024
The Omission of Upfront Treatment Intensification Does Not Adversely Affect Oncological Outcomes in a Subset of Castration-Highly Sensitive Metastatic Prostate CancerNaohiro Fujimoto, Yujiro Nagata, Masaki Shiota, et al.
World Journal of Urology|May 7, 2026
Quantifying ergonomic challenges for urologists operating flexible ureteroscopes through artificial intelligence-based posture estimationSatoshi Kobayashi, Keiji Tsukino, Mikifumi Koura, et al.
Cancer Medicine|June 30, 2022
Conceptual assessment of HRQOL among Japanese non-metastatic castration-resistant prostate cancer (nmCRPC) patientsKazuo Nishimura, Masaki Shiota, Masatoshi Eto, et al.
The Prostate|November 26, 2009
Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleusMasaki Shiota, Akira Yokomizo, Daisuke Masubuchi, et al.
Cyborg and Bionic Systems (Washington, D.C.)|April 17, 2023
Surgical Robot for Intraluminal Access: An Ex Vivo Feasibility StudyRyu Nakadate, Tsutomu Iwasa, Shinya Onogi, et al.
Oncology Reports|February 17, 2015
C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathwaysYoshihiro Maeda, Yoshiaki Kawano, Yoshihiro Wada, et al.
Cancer Research|November 4, 2005
Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in miceMasahiko Harano, Masatoshi Eto, Toshiro Iwai, et al.
Anticancer Research|February 7, 2016
Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder CancerKeijiro Kiyoshima, Masakazu Akitake, Masaki Shiota, et al.
Prostate International|April 8, 2020
Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancerEiji Kashiwagi, Masaki Shiota, Hiroyuki Masaoka, et al.
JMA Journal|November 21, 2022
Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with EnzalutamideEiji Kashiwagi, Masaki Shiota, Ken Lee, et al.
Pageof 41